ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Oxford Square Capital Corporation

Oxford Square Capital Corporation (OXSQL)

25.32
0.00
(0.00%)
Closed June 18 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
25.32
Bid
18.54
Ask
25.37
Volume
-
0.00 Day's Range 0.00
24.66 52 Week Range 25.34
Market Cap
Previous Close
25.32
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
58,130,000
Dividend Yield
6.42%
PE Ratio
77.54
Earnings Per Share (EPS)
0.3
Revenue
51.82M
Net Profit
17.24M

About Oxford Square Capital Corporation

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Website
Headquarters
Baltimore, Maryland, USA
Founded
1970
Oxford Square Capital Corporation is listed in the Unit Inv Tr, Closed-end Mgmt sector of the NASDAQ with ticker OXSQL. The last closing price for Oxford Square Capital was $25.32. Over the last year, Oxford Square Capital shares have traded in a share price range of $ 24.66 to $ 25.34.

Oxford Square Capital currently has 58,130,000 shares outstanding. The market capitalization of Oxford Square Capital is $1.34 billion. Oxford Square Capital has a price to earnings ratio (PE ratio) of 77.54.

OXSQL Latest News

Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended December 31, 2023 and Declaration of Distributions on Common Stock for the Months Ending April 30, May 31, and June 30, 2024.

GREENWICH, Conn., March 15, 2024 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,” “we,” “us” or “our”) announced today its...

Oxford Square Capital Corp. Schedules Fourth Quarter 2023 Earnings Release and Conference Call for March 15, 2024

GREENWICH, Conn., March 12, 2024 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) announced today that it will hold a conference call to...

Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended September 30, 2023 and Declaration of Distributions on Common Stock for the Months Ending January 31, February 29, and March 31, 2024

GREENWICH, Conn., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,” “we,” “us” or “our”...

Oxford Square Capital Corp. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 7, 2023

Greenwich, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) announced today that it will hold a...

Oxford Square Capital Corp. Announces Partial Redemption of 6.50% Notes Due 2024

GREENWICH, Conn., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,” “we,” “us” or “our”...

Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2023

GREENWICH, Conn., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,” “we,” “us” or “our”...

Oxford Square Capital Corp. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023

GREENWICH, Conn., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) announced today that it will hold a...

Oxford Square Capital Corp. Announces Partial Redemption of 6.50% Notes Due 2024

GREENWICH, Conn., June 22, 2023 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,” “we,” “us” or “our”...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
26-0.02-0.078926598263625.3425.3425.0333625.32318927CS
520.582.3443815683124.7425.3424.66168025.00893002CS
1560.050.1978630787525.2725.5423.96256324.96092925CS
2600.050.1978630787525.2726.35311.9203349223.60254747CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMTLComtech Telecommunications Corporation
$ 4.07
(87.56%)
91.43M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.36M
ASNSActelis Networks Inc
$ 2.11
(83.48%)
51.37M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
LRHCLa Rosa Holdings Corporation
$ 1.78
(71.15%)
52.9M
STISolidion Technology Inc
$ 0.6881
(-64.35%)
16.36M
DMTKDermTech Inc
$ 0.1488
(-55.25%)
10.74M
QMCOQuantum Corporation
$ 0.3752
(-51.90%)
3.14M
ZNTLZentalis Pharmaceuticals Inc
$ 4.135
(-50.72%)
21.58M
AWINAERWINS Technologies Inc
$ 1.74
(-47.90%)
1.05M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.36M
NVDANVIDIA Corporation
$ 135.58
(3.51%)
294.32M
MBIOMustang Bio Inc
$ 0.8517
(13.56%)
291.95M
CRKNCrown Electrokinetics Corporation
$ 0.0548
(-17.10%)
92.39M

Discussion

View Full Feed
Saving Grace Saving Grace 3 minutes ago
$NRDE Winning! Wait for the announcements, It's going to be big, in fact huge when the NDA's come off.

https://i.vimeocdn.com/video/1780032285-1eadf9821975b71cc554aa3a7d443a4b59265d9b3a16081b2573d7c443765305-d.webp?mw=1100&mh=619&q=70

https://cc.tvbs.com.tw/2017program
NRDE
FranksAlot FranksAlot 4 minutes ago
So what does this all mean in the grand scheme of things
RNVA
thegoodnessparadox thegoodnessparadox 4 minutes ago
Looking forward to the Beneficial Owner: Definition, Transparency, & Tax Implications events on the horizon. They can't come soon enough, especially with what is reported to be a "wall of money" that is in the Inflation Reduction Act. Have you read the signs in many American cities and towns? They r
GNCP
janice shell janice shell 6 minutes ago
I think it is important. However, so is the vote of people who feel Bibi just wants to kill everyone in Gaza. It's a huge headache for Biden.
Eli's Gone Eli's Gone 6 minutes ago
https://www.cbssports.com/mlb/news/aaron-judge-injury-yankees-slugger-gets-clean-test-results-after-getting-hit-by-pitch-on-the-hand/


New York Yankees star and super early AL MVP candidate Aaron Judge does not have a fracture in his left hand after being hit by a pitch in Tues
axelvento axelvento 7 minutes ago
Bird flu infects seventh Iowa dairy farm, state agency says

https://eu.desmoinesregister.com/story/money/agriculture/2024/06/17/bird-flu-pandemic-iowa-seventh-dairy-farm-infected-sioux-county/74129029007/
MRNA
StockItOut StockItOut 7 minutes ago
You actually think he's developing a "world changing product?" That has got to be the craziest conspiracy theory you've ever come up with.

Why would anyone endorse Retacell for years, dump Movychem and steal its Retacell IP claiming that Movychem could not produce the Xeriant-stated
XERI
APR APR 8 minutes ago
Don't take it personally, we're just helping you out with your poor grammar
Then we will work on your math
What a penny looks like
PSRU
Scott ruby Scott ruby 8 minutes ago
Hi it seems a deal was offered in January as per docket that was released today .please take a look it was sent by jho at 731 pm and it's circulating on other boards .
EBET
Deportes Deportes 10 minutes ago
Buy into another scam. Don’t think so. Soooon. NDAs. C’mon
ENZC
KILLAZILLA KILLAZILLA 12 minutes ago
pusi??? MORE INSULTS....

TIME FOR you TO STFU FROM THE BENCH....
XERI
brooktrail1933 brooktrail1933 13 minutes ago
I think you have the wrong poster.
NWBO
axelvento axelvento 14 minutes ago
Nearly 75% of patients that received the experimental vaccine Moderna and Merck developed, along with Keytruda, were alive without any signs or symptoms of their cancer returning after two and a half years. The overall survival rate of those patients who received the combined treatment that Moderna
MRNA
dloggold dloggold 14 minutes ago
and who owns 110 mm shares ?
delusion runs wild here
HGENQ
Landmark8211111 Landmark8211111 14 minutes ago
It’s Very painful to watch! …!

Never would have thought it would be possible to CRASH-OUT !
NB
Jimmy Joe Jimmy Joe 15 minutes ago
in 10 days, I'll be at 1,200%,

Anything is possible....... sunshine.
GME
fuagf fuagf 16 minutes ago
Agree. How important is the 'sympathy for Israel Jewish vote' in the election. Must look into that. Hard to balance domestic politics with geopolitical reality. Biden being a long term real fan of Israel must make it even tougher for him. Netanyahu's confidence the US will just keep giving, while
FelixOTC FelixOTC 16 minutes ago
Hey! Good job swapping out whatever copy paste stock you have for civx. You're getting the hang of it. Proud of you buddy.

Civx is going to do great and I hope you get to capitalize with us
CIVX
Whalatane Whalatane 17 minutes ago
RMB. Germany follows a different method on determining reimbursement then most of the other EU countries . Each EU is different but Germany stands out .

Taken another way ...any drug that gets reimbursed in Germany is almost certain to be reimbursed in the rest of the EU
AMRN
Jimmy Joe Jimmy Joe 17 minutes ago
Yeah sunshine, make sure you come back to cry on our shoulders. Keep writing PUTS.

Huffing glue isn't good to do. Just saying............ stunts growth Shorty.
GME
Money4Nothing-M4N Money4Nothing-M4N 17 minutes ago
TLDR… the obvious tell.

Geez. I wonder which poster on the facebook message board also suffers from diarrhea of the mouth and chronic kvetching over minutiae?

I guess it’s a mystery.
KBLB

Your Recent History

Delayed Upgrade Clock